RESUMEN
BACKGROUND: The COVID-19 pandemic necessitated a time-critical expansion of medical staff in intensive care units (ICU) and emergency rooms (ER). OBJECTIVE: This article describes the development, performance and first results of an interprofessional blended learning concept called hospital paramedics, qualifying paramedics and additional medical personnel to support ICUs and ERs. MATERIAL AND METHODS: The Protestant Hospital of the Bethel Foundation (EvKB), University Hospital OWL, University of Bielefeld in cooperation with the Study Institute Westfalen-Lippe, developed a 2-stage blended learning concept (stage 1 elearning with online tutorials, stage 2 practical deployment) comprising 3 modules: ICU, ER and in-hospital emergency medicine. At the beginning, the participants were asked about their sociodemographic data (age, gender, type of medical qualifications) and subjective feeling of confidence. At the end, a final discussion with the participant, the practice instructor and the supervising physician took place and an evaluation of the deployment by the head of the practice and the hospital paramedic was carried out using questionnaires. RESULTS: Within 6 weeks 58 (63%) of the 92 participants completed the online course and 17 (29%) additionally completed their traineeship. In the ICU they assisted with preparing catheter systems, medication and nursing, performed Manchester triage and initial care in the ER. After completion hospital paramedics were significantly more confident when working in a hospital, catheterization and tracheostoma care (pâ¯< 0.05). Of the supervisors 94% deemed the deployment as useful and 100% of the participants were prepared to be available at short notice in their areas as compensation for the COVID-19-pandemic in the event of a staff shortage. Through the provision of additional intensive care ventilators and monitoring units in the period from March to the beginning of May 2020 and the personnel management that was carried out, the EvKB was in a position to increase the number of previously provided ventilator beds by potentially >40 ventilation places. CONCLUSION: Blended learning concepts, such as hospital paramedics, can quickly qualify medical personnel for use in system-relevant settings, relieve nursing staff and thus create an expansion of intensive care capacities. Existing or pending pandemic and contingency plans should be complemented by such blended learning training so that they are immediately available in case of a second pandemic wave, future pandemics or other crisis situations.
Asunto(s)
Técnicos Medios en Salud/educación , COVID-19/terapia , Servicio de Urgencia en Hospital/organización & administración , Personal de Salud/educación , Unidades de Cuidados Intensivos/organización & administración , Educación Interprofesional/métodos , COVID-19/epidemiología , COVID-19/enfermería , Cuidados Críticos/métodos , Auxiliares de Urgencia/educación , Humanos , SARS-CoV-2/aislamiento & purificación , Ventiladores Mecánicos , Voluntarios/educaciónRESUMEN
Despite considerable basic research into the mechanisms of atrial fibrillation (AF), not much progress has been made in the prognosis of patients with AF. With the exception of anticoagulant therapy, current treatments for AF still do not improve major cardiovascular outcomes. This may be due partly to the diverse aetiology of AF with increasingly more factors found to contribute to the arrhythmia. In addition, a strong increase has been seen in the technological complexity of the methods used to quantify the main pathophysiological alterations underlying the initiation and progression of AF. Because of the lack of standardization of the technological approaches currently used, the perception of basic mechanisms of AF varies widely in the scientific community. Areas of debate include the role of Ca(2+) -handling alterations associated with AF, the contribution and noninvasive assessment of the degree of atrial fibrosis, and the best techniques to identify electrophysiological drivers of AF. In this review, we will summarize the state of the art of these controversial topics and describe the diverse approaches to investigating and the scientific opinions on leading AF mechanisms. Finally, we will highlight the need for transparency in scientific reporting and standardization of terminology, assumptions, algorithms and experimental conditions used for the development of better AF therapies.
Asunto(s)
Fibrilación Atrial/etiología , Animales , Señalización del Calcio/fisiología , Modelos Animales de Enfermedad , Perros , Humanos , Ratones , Remodelación Vascular/fisiologíaRESUMEN
INTRODUCTION: 17 years ago the first radiofrequency catheter ablation of an accessory pathway (AP) was performed. The aim of this study was to describe the contemporary success rates and procedure related complication rates of radiofrequency (RF) ablation of accessory pathways (APs). In addition, the present study describes the anatomical distribution of APs according to the new nomenclature introduced by NASPE and ESC in 1999. METHODS: The analysis included all patients, who underwent RF ablation of an AP in the Heart Center Leipzig between January 2000 and December 2003. RESULTS: Over a 4 year period 336 APs were ablated in 323 patients. 201 APs (60%) presented with antegrade and retrograde conduction and showed preexcitation on ECG. For the remaining 135 APs (40%), only retrograde conduction over the AP was documented. According to the new nomenclature APs were classified as left-sided, right sided, septal and paraseptal APs. 188 APs (56%) were located on the left, 41 (12%) on the right, 64 (19%) in the paraseptal space and 31 APs (9%) presented with a septal or parahisian localization, respectively. Because of atypical course and/or characteristics 12 APs (4%) could not be classified. Ablation of all pathways were successful in 315 patients (98%). In 289 patients (89%) success was achieved within a single ablation session. The left-sided pathways had a re-intervention rate of 5%, which was significantly lower compared to the remaining localizations. The highest re-intervention rate was observed in the septal APs (23%). Complications were observed in less than 2% of all treated patients. CONCLUSIONS: 17 years after the first RF catheter ablation of an AP this therapy is established as a highly effective procedure. The success rate has improved to 98% and the complication rate has been minimized to less than 2%. The most frequent localization of APs is left posterior. Left sided APs also presented with the lowest re-intervention rate. The introduction of the new nomenclature in 1999 by NASPE and ESC has simplified the description of the exact anatomical localization of an AP.
Asunto(s)
Ablación por Catéter/métodos , Síndromes de Preexcitación/cirugía , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Nodo Atrioventricular/lesiones , Ablación por Catéter/efectos adversos , Niño , Preescolar , Electrocardiografía , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Marcapaso Artificial , Complicaciones Posoperatorias/etiología , Complicaciones Posoperatorias/terapia , Síndromes de Preexcitación/diagnóstico , Recurrencia , Reoperación , Estudios Retrospectivos , Resultado del TratamientoRESUMEN
OBJECTIVE: To test the hypothesis that atrial fibrillation (AF) is associated with changes in the expression of connexins 40 and 43 in the left atrium with more pronounced changes in mitral valve disease than in lone AF. METHODS: Protein concentrations of connexin 40 and connexin 43 were analysed in left atrial tissue of patients undergoing cardiac surgery. One group of patients had lone AF (n = 41), one group had AF and mitral valve repair (n = 36), and one group in sinus rhythm served as controls (n = 15). RESULTS: Western blot analysis of connexin 40 and connexin 43 expression showed an increase of both gap junctional proteins (connexin 43 > connexin 40) in patients with AF of all forms compared with patients in sinus rhythm (p = 0.01 and p = 0.011, respectively). Subgroup analysis showed increased concentrations of connexin 40 in lone AF and AF with mitral valve disease compared with sinus rhythm (p = 0.06 and p = 0.029, respectively), whereas the same analysis for connexin 43 reached significance only in the mitral valve disease group (p = 0.031). No differences in connexin 40 and connexin 43 expression were detectable between lone AF and AF with mitral valve disease. Within the groups connexin 40 and connexin 43 expression did not differ between patients with paroxysmal AF and patients with chronic AF. CONCLUSION: The present study shows for the first time that AF can induce changes in the left atrium with increased connexin expression. Furthermore, no systematic differences between patients with paroxysmal and chronic AF were detected.
Asunto(s)
Fibrilación Atrial/metabolismo , Conexina 43/metabolismo , Conexinas/metabolismo , Miocardio/metabolismo , Fibrilación Atrial/etiología , Western Blotting , Estudios de Casos y Controles , Atrios Cardíacos , Humanos , Persona de Mediana Edad , Mitragyna , Proteína alfa-5 de Unión ComunicanteRESUMEN
The purpose of an electrophysiological study is to verify the mechanism of arrhythmias and to decide the means of therapy for the clinical arrhythmia (pharmacological, radiofrequency catheter ablation, pacemaker-, ICD-implantation). The electrode catheters are introduced percutaneously into the right atrium, to the His-bundle, into the coronary sinus and/or into the right ventricle. By this electrode catheters the intracardiac electrograms are registered and programmed stimulation of the heart is performed. The electrical conduction properties are analysed. With stimulation manoeuvres most of the clinical tachycardias can be induced. In the first part of this overview we describe the procedure of an electrophysiological study, in the second part the indications are discussed.
Asunto(s)
Bradicardia/etiología , Cateterismo Cardíaco , Electrocardiografía , Taquicardia/etiología , Antiarrítmicos/uso terapéutico , Bradicardia/diagnóstico , Bradicardia/terapia , Estimulación Cardíaca Artificial , Ablación por Catéter , Desfibriladores Implantables , Sistema de Conducción Cardíaco/fisiopatología , Humanos , Marcapaso Artificial , Taquicardia/diagnóstico , Taquicardia/terapiaRESUMEN
Atrial fibrillation is the most frequent sustained arrhythmia, especially in the elderly. Atrial fibrillation often is precipitated by underlying cardiac or noncardiac disease, but it may also occur as 'lone atrial fibrillation'. Hemodynamic impairment and thromboembolic events are leading to an important morbidity, mortality and health costs. This review-article describes the actual management of this common arrhythmia.
Asunto(s)
Fibrilación Atrial , Anciano , Anciano de 80 o más Años , Antiarrítmicos/uso terapéutico , Anticoagulantes/uso terapéutico , Fibrilación Atrial/clasificación , Fibrilación Atrial/diagnóstico , Fibrilación Atrial/tratamiento farmacológico , Fibrilación Atrial/epidemiología , Fibrilación Atrial/etiología , Fibrilación Atrial/cirugía , Fibrilación Atrial/terapia , Ablación por Catéter , Cardioversión Eléctrica , Electroencefalografía , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Recurrencia , Factores de TiempoRESUMEN
Within the past 20 years, refinements in electrophysiologic mapping techniques have provided a better understanding of the pathophysiology of atrial flutter and atrial fibrillation (AF), which resulted in the development of catheter ablation techniques for this arrhythmias. Nowadays, catheter ablation has become the first line treatment of recurrent symptomatic or hemodynamically significant atrial flutter. In contrast, catheter ablation of AF is still an investigational procedure and should be restricted to patients with symptomatic AF who have been refractory to multiple antiarrhythmic drugs. In symptomatic patients with AF and an uncontrolled ventricular rate who have failed treatment with several antiarrhythmic drugs and who do not fit for primary catheter ablation of AF atrioventricular junction ablation with prior pacemaker implantation is recommended.
Asunto(s)
Fibrilación Atrial/cirugía , Aleteo Atrial/cirugía , Ablación por Catéter , Antiarrítmicos/uso terapéutico , Fibrilación Atrial/tratamiento farmacológico , Fibrilación Atrial/fisiopatología , Aleteo Atrial/fisiopatología , Electrocardiografía , Humanos , Marcapaso Artificial , Selección de Paciente , RecurrenciaRESUMEN
OBJECTIVE: To examine the hypothesis that major extracellular matrix (ECM) proteins are expressed differently in the left atrial tissue of patients in sinus rhythm (SR), lone atrial fibrillation (AF), and AF with underlying mitral valve disease (MVD). DESIGN: Case-control study. PATIENTS: 118 patients with lone AF, MVD+AF, and SR. MAIN OUTCOME MEASURES: Collagen I, collagen III, and fibronectin protein expression measured by quantitative western blotting techniques and immunohistochemical methods. RESULTS: Protein concentrations increased in patients with AF (all forms) compared with those in SR (all forms): collagen I (1.15 (0.11) v 0.45 (0.28), respectively; p = 0.002), collagen III (0.74 (0.05) v 0.46 (0.11); p = 0.002, and fibronectin (0.88 (0.06) v 0.62 (0.13); p = 0.08). Especially, collagen I was similarly enhanced in both lone AF (1.49 (0.15) and MVD+AF (1.53 (0.16) compared with SR (0.56 (0.28); both p = 0.01). Collagen III was not significantly increased in lone AF but was significantly increased in AF combined with MVD (0.84 (0.07) both compared with SR (0.46 (0.11); p = 0.01). The concentration of fibronectin was not significantly increased in lone AF and MVD+AF (both compared with SR). Furthermore, there was a similar degree of enhanced collagen expression in paroxysmal AF and chronic AF. CONCLUSIONS: AF is associated with fibrosis. Forms of AF differ from each other in collagen III expression. However, there was no systematic difference in ECM expression between paroxysmal AF and chronic AF. Enhanced concentrations of ECM proteins may have a role in structural remodelling and the pathogenesis of AF as a result of separation of the cells by fibrotic depositions.
Asunto(s)
Fibrilación Atrial/patología , Atrios Cardíacos/patología , Enfermedades de las Válvulas Cardíacas/patología , Válvula Mitral/patología , Western Blotting , Estudios de Casos y Controles , Enfermedad Crónica , Colágeno Tipo I/metabolismo , Colágeno Tipo III/metabolismo , Fibronectinas/metabolismo , Fibrosis , Humanos , Inmunohistoquímica , Persona de Mediana EdadRESUMEN
Atrial fibrillation in patients with isolated, therapy resistant, chronic or paroxysmal atrial fibrillation (AF) or AF in combination with additional valvular and non-valvular cardiac pathology can be surgically treated by different techniques. Unipolar high frequency, cryotherapy and microwave energy is a curative approach for the treatment of the left atrium for AF. The postoperative mortality and morbidity rate is comparable to other cardiac surgery procedures. It is a technically less challenging procedure as compared to the MAZE procedure and can be applied using a minimally invasive approach. Alternative techniques such as new cryotechnologies, laser application and bipolar high frequency energy need to be evaluated for effectiveness and safety.
Asunto(s)
Fibrilación Atrial/cirugía , Procedimientos Quirúrgicos Cardiovasculares/métodos , Ablación por Catéter/métodos , Criocirugía/métodos , Terapia por Láser/métodos , Microondas/uso terapéutico , Fibrilación Atrial/terapia , Humanos , Periodo Posoperatorio , Recurrencia , Insuficiencia del Tratamiento , Resultado del TratamientoRESUMEN
We report 3 adolescents with structurally normal heart who were referred to hospital due to long-lasting palpitations. Initial 12-lead-ECG showed sustained, monomorphic ventricular tachycardia, right bundle branch block QRS morphology and axis deviation. After failure of different anti-arrhythmic drugs finally the intravenous medication with verapamil led to termination of ventricular tachycardia in all three patients. All clinical findings and the responsiveness to verapamil are consistent with the diagnosis of idiopathic left ventricular tachycardia. In one patient an electrophysiological study was done and increased left ventricular vulnerability was shown. After inducing a tachycardia originating from the left ventricle radiofrequency catheter ablation of the left-posterior fascicle was successfully performed. The tachycardia was not inducible after this ablation. Since that investigation the patient has been asymptomatic without anti-arrhythmic treatment. Two of three patients have been on oral verapamil prophylactically and have been free of symptoms.
Asunto(s)
Bloqueo de Rama/diagnóstico , Electrocardiografía , Taquicardia Ventricular/diagnóstico , Administración Oral , Adolescente , Antiarrítmicos/administración & dosificación , Bloqueo de Rama/terapia , Estimulación Cardíaca Artificial , Ablación por Catéter , Estudios de Seguimiento , Humanos , Infusiones Intravenosas , Cuidados a Largo Plazo , Masculino , Taquicardia Ventricular/terapia , Verapamilo/administración & dosificaciónRESUMEN
AIMS: We describe a new strategic stepwise mapping approach for fast and accurate identification and ablation of ectopic atrial foci using an electroanatomic mapping system. METHODS AND RESULTS: Mapping procedures started with the acquisition of four points at the superior/septal part of the tricuspid annulus. According to this activation sequence, maps were continued towards the right atrial free wall if relatively early activation was shown at the superior part of the initial map or towards the triangle of Koch and, if necessary, to the left atrium, in cases of relatively early activation at the septum. High density mapping and detailed electrogram analysis only of the target area allowed identification and ablation of 34 foci in 30 of the 32 studied consecutive patients. A small number of mapping points were sufficient within a procedure time of 90 +/- 41 min for right 148 +/- 68 min and for left sided foci and a total fluoroscopy time of 9.6 +/- 7.2 min and 24.8 +/- 16.4 min respectively. Sixteen foci were located at the right free wall, eight at the left free wall, and 10 at the right or left side of the septum. CONCLUSION: Strategic electroanatomic mapping with fast identification of the area of tachycardia origin and high density mapping only of this target area allowed fast and successful localization and ablation of right and left free wall and septal ectopic atrial foci.
Asunto(s)
Ablación por Catéter , Técnicas Electrofisiológicas Cardíacas/métodos , Taquicardia Atrial Ectópica/terapia , Adolescente , Anciano , Niño , Fenómenos Electromagnéticos , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
OBJECTIVE: The efficacy of the left atrial radiofrequency ablation procedure, for the curative treatment of atrial fibrillation, is dependent upon obtaining a confluent transmural line of hyperthermic cellular death. We compare the in vitro effectiveness of obtaining transmural hyperthermic cellular death (>55 degrees C) of both the Osypka single electrode and Boston Scientific Thermaline multi-electrode radiofrequency systems. METHODS: Isolated cadaver porcine hearts were used to measure epicardial temperatures either 'central' or at the 'edge' in relation to an endocardial applied radiofrequency electrode. Reference set point was 70 degrees C, and 4-6-mm thick atrial tissue was used for all applications. 'Edge' temperatures with the Boston Scientific unit were measured whilst activating both adjacent electrodes. RESULTS: Boston Scientific: Probe temperature closely approximated the set point. 'Central' epicardial temperature was lower than probe temperature until after 40 s application (P<0.05), 55 degrees C was reached at 50 s, maximal mean temperature 63.0+/-8.9 degrees C was reached at 100 s. Epicardial 'edge' temperature remained lower than probe temperature for the entire 120 s (P<0.05). Osypka: Probe temperature tended to overshoot the set point. 'Central' epicardial temperature paralleled and occasionally exceeded probe temperature reaching 55 degrees C within 10 s, maximal mean temperature 76.3+/-12.7 degrees C was reached at 10 s and exceeded the set point thereafter. 'Edge' temperature was no different to probe temperature or 'central' epicardial temperature. The mean epicardial temperatures produced with a 65 degrees C set point was no different to that with the 70 degrees C set point, except for a lower final temperature at 60 s. CONCLUSIONS: The Boston Scientific system (70 degrees C set point) requires a minimum in vitro application of 40 s to transmurally increase 4-6 mm atrial tissue temperature above 55 degrees C, and 120-s duration per application would appear to be a reasonable clinical recommendation. The Osypka system transfers thermal energy more effectively, requiring less than 10 s in vitro to achieve a similar transmural temperature, and a 30-s application can be recommended. However, a tendency to overshoot both probe and set point temperature, suggests that a lower set point of 65 degrees C might be safer and as effective.
Asunto(s)
Ablación por Catéter/instrumentación , Animales , Técnicas In Vitro , Porcinos , TemperaturaRESUMEN
BACKGROUND: Catheter ablation of pulmonary vein ectopic foci is a potentially curative treatment strategy for patients with atrial fibrillation. However, identification of arrhythmogenic pulmonary veins with conventional mapping is difficult, especially in patients with rare focal activity, multiple active foci, or extrapulmonary foci. The present study was designed to investigate use of simultaneous noncontact mapping in this setting. METHODS AND RESULTS: In 17 consecutive patients with paroxysmal atrial fibrillation, a catheter-mounted noncontact multielectrode array positioned in the left atrium was used to reconstruct 3300 electrograms simultaneously from a single beat. Isopotential maps were generated during sinus rhythm and focal activity. After ectopic foci were identified, radiofrequency catheter ablation was performed in patients with 1 or 2 foci. However, in patients who had multiple foci, intraoperative ablation of atrial fibrillation was advised. A total of 28 ectopic foci (25 pulmonary vein foci and 3 extrapulmonary vein foci) were identified by use of isopotential maps generated from a single beat of focal activity. Radiofrequency catheter ablation guided by noncontact mapping was attempted in 12 patients with 1 or 2 ectopic foci. Successful ablation of atrial fibrillation was achieved in 9 of 12 patients (75%). CONCLUSIONS: Noncontact mapping allows rapid and precise identification of arrhythmogenic pulmonary veins in addition to extrapulmonary vein foci. Thus, the present study shows that the technology may be used not only to guide radiofrequency catheter ablation, but also as a diagnostic tool to develop individual treatment strategies.
Asunto(s)
Fibrilación Atrial/diagnóstico , Fibrilación Atrial/fisiopatología , Mapeo del Potencial de Superficie Corporal/métodos , Atrios Cardíacos/fisiopatología , Venas Pulmonares/fisiopatología , Fibrilación Atrial/cirugía , Mapeo del Potencial de Superficie Corporal/instrumentación , Cateterismo Cardíaco/instrumentación , Ablación por Catéter/efectos adversos , Técnicas Electrofisiológicas Cardíacas/métodos , Estudios de Factibilidad , Femenino , Estudios de Seguimiento , Atrios Cardíacos/cirugía , Humanos , Masculino , Microelectrodos , Persona de Mediana Edad , Venas Pulmonares/cirugía , Resultado del TratamientoRESUMEN
Curative treatment of chronic atrial fibrillation (AF) remains a challenging task for electrophysiologists. Eliminating the initiating triggers by focal radiofrequency ablation in a subset of patients with paroxysmal AF and modifying the maintaining substrate by performing linear lesions within the left atrium in patients with prolonged episodes of AF are among the alternative approaches for management of these patients. Recently, a new intraoperative treatment procedure aimed at eliminating left atrial anatomic "anchor" reentrant circuits by induction of contiguous lesions using radiofrequency energy under direct vision was introduced. However, atypical left atrial flutter may occur during follow-up after intraoperative ablation of AF. These arrhythmias most likely are due to discontinuities in linear lesions; therefore, they can be successfully mapped and ablated in a subsequent percutaneous catheter ablation procedure. We report and discuss the case of a patient who underwent successful intraoperative ablation of chronic AF, but who developed atypical left atrial flutter postoperatively. Three-dimensional nonfluoroscopic electroanatomic mapping revealed a gap in the linear lesion line connecting the left upper and right upper pulmonary vein orifices. Ablation at the exit site of the breakthrough was successful.
Asunto(s)
Fibrilación Atrial/complicaciones , Fibrilación Atrial/cirugía , Aleteo Atrial/etiología , Ablación por Catéter , Anciano , Mapeo del Potencial de Superficie Corporal/estadística & datos numéricos , Procedimientos Quirúrgicos Cardíacos , Ablación por Catéter/efectos adversos , Enfermedad Crónica , Técnicas Electrofisiológicas Cardíacas , Femenino , Humanos , Cuidados Intraoperatorios , Complicaciones Posoperatorias/etiologíaRESUMEN
OBJECTIVES: This study is designed to examine the immediate and short-term outcomes of patients who have undergone slow pathway ablation/modification for atrioventricular nodal reentrant tachycardia. BACKGROUND: Targeting the slow pathway has emerged as the superior form of treatment for atrioventricular nodal reentrant tachycardia. This technique has been found effective and is associated with a low complication rate. However, little is known of the long-term outcome of patients undergoing this procedure. METHODS: Over a 40-month period the slow pathway was targeted in 379 consecutive patients with proven atrioventricular nodal reentrant tachycardia. The case records of all patients were examined. Accurate follow-up data is available in 96% of patients a mean of 20.6 months after the procedure. RESULTS: The initial success rate was 97%. The incidence of complete heart block was 0.8% and the mean fluoroscopy duration was 27.3 min. The recurrence rate was 6.9%. Age, number of pulses and fluoroscopy time were positively associated with either initial failure or recurrence. A total of 11.3% of patients were still taking antiarrhythmic medication at follow-up. CONCLUSIONS: Targeting the slow pathway is an effective form of treatment for atrioventricular nodal reentrant tachycardia. The technique has a high initial success rate, a low complication rate and a low recurrence rate at long-term follow-up. Slow pathway modification is associated with similar success rates and recurrence rates as slow pathway ablation and may confer theoretical long-term benefits.
Asunto(s)
Ablación por Catéter , Sistema de Conducción Cardíaco/cirugía , Taquicardia por Reentrada en el Nodo Atrioventricular/cirugía , Técnicas Electrofisiológicas Cardíacas , Femenino , Estudios de Seguimiento , Bloqueo Cardíaco/epidemiología , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Recurrencia , Taquicardia por Reentrada en el Nodo Atrioventricular/epidemiología , Factores de Tiempo , Resultado del TratamientoRESUMEN
BACKGROUND: The aim of this study was to evaluate the results of combined stentless mitral valve (SMV) replacement and intraoperative radiofrequency ablation for chronic atrial fibrillation (IRAAF) to restore physiologic hemodynamic function. METHODS: Since July 1998 12 patients (72+/-4 years, 10 women, mitral stenosis/mitral incompetence 8/4, NYHA 3.3+/-0.4, CI 1.8+/-0.5) had SMV implantation and received additional IRAAF by inducing continuous left atrial lesion lines from the MV annulus to all four pulmonary veins and to the atriotomy. RESULTS: The flexible SMV was implanted at the papillary muscles and at the annulus using a conventional (n = 6) or a minimally invasive approach (n = 6). Sinus rhythm was successfully restored in 10 of 12 patients with 6- and 12-months' follow-up; 2 required DDD-pacemaker implantation. However, in the early postoperative period several interventions including medical treatment (sotalol or amiodarone) in 9 and electrical cardioversion in 7 patients was required. Two patients required reinterventions: 1 cardioversion and 1 amiodarone medication after 3 and 6 months, respectively. At echocardiography the SMV demonstrated good hemodynamic function and atrial contraction. CONCLUSIONS: Restoration of physiologic cardiac function by SMV implantation and IRAAF is advantageous and no further anticoagulation is required.
Asunto(s)
Fibrilación Atrial/cirugía , Ablación por Catéter , Implantación de Prótesis de Válvulas Cardíacas , Insuficiencia de la Válvula Mitral/cirugía , Estenosis de la Válvula Mitral/cirugía , Válvula Mitral/cirugía , Anciano , Enfermedad Crónica , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Procedimientos Quirúrgicos Mínimamente Invasivos , Resultado del TratamientoRESUMEN
BACKGROUND: Radiofrequency catheter ablation within the tricuspid annulus-inferior caval vein isthmus can cure typical atrial flutter. The target for ablation, nonetheless, is relatively wide, and standard ablation procedures may require significant exposure to radiation. METHODS AND RESULTS: A total of 50 patients (mean age, 58+/-11 years) with typical atrial flutter were prospectively randomized to receive isthmus ablation using conventional fluoroscopy for catheter navigation (group I, n=24) or electromagnetic mapping (group II, n=26). Complete bidirectional isthmus block was verified with double potential mapping. If complete isthmus block could not be achieved after 20 radiofrequency pulses or 25 minutes of fluoroscopy, the patients were switched to the other group. Eight patients from group I (33%) but only 1 patient from group II (4%) were switched. Overall, complete isthmus block was achieved in 47 of 50 patients (94%). The overall fluoroscopy time, including the placement of the diagnostic catheters, was 22.0+/-6.3 minutes in group I and 3.9+/-1.5 minutes in group II (P:<0.0001). The fluoroscopy time needed for isthmus mapping was 17.7+/-6.5 minutes in group I and 0.2+/-0.3 minutes in group II (P:<0.0001). CONCLUSIONS: Electromagnetic mapping during the induction of linear lesions for the ablation of atrial flutter permitted a highly significant reduction in exposure to fluoroscopy while maintaining high efficacy, and it allowed the time required for fluoroscopy to be reduced to levels anticipated for diagnostic electrophysiological studies.
Asunto(s)
Aleteo Atrial/cirugía , Ablación por Catéter , Fenómenos Electromagnéticos/métodos , Femenino , Fluoroscopía/métodos , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Factores de TiempoRESUMEN
HISTORY: While cycling a 38-year-old man suddenly experienced palpitations associated with marked weakness. 90 min later his general practitioner, having diagnosed a ventricular tachycardia (VT) with a rate of 218/min, terminated it by a drug injection. INVESTIGATIONS: Electrocardiography (ECG), echocardiography and biventricular cardiac catheterization with right ventricular contrast injection failed to provide any evidence of structural abnormality. However, ergometry and EPS with programmed ventricular stimulation induced VT of identical morphology (left bundle branch bloc [LBBB] with right axis deviation [RAD]). TREATMENT AND COURSE: Idiopathic right-ventricular outflow tract tachycardia (IRVT) having been diagnosed, the patient was put on a maintenance dose of 50 mg/d atenolol. After 6 months without symptoms he again experienced several attacks of tachycardia. Resting ECG merely revealed an epsilon potential and negative T waves in V1-V3. Right ventricular contrast injection revealed inferolateral dyskinesia. EPS demonstrated both the known VT and a second, morphologically different one (LBBB with LAD). These findings indicated arrhythmogenic right-ventricular cardiomyopathy (ARCV). A cardioverter/defibrillator was implanted (ICD) and over the subsequent 8 months he had six episodes of VT which were quickly terminated by the ICD. CONCLUSION: At first presentation of right-ventricular outflow tract tachycardia it is often not possible to differentiate between IRVT and arrhythmogenic RV cardiomyopathy. The two being significantly different in prognosis and treatment, follow-up monitoring is essential to establish the definitive diagnosis.